Dalton, Greiner, Hartman, Maher & Co’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-21,948
Closed -$1.4M 134
2021
Q1
$1.4M Sell
21,948
-10,116
-32% -$587K 1.11% 20
2020
Q4
$1.68M Sell
32,064
-5,415
-14% -$267K 0.35% 81
2020
Q3
$1.64M Sell
37,479
-11,022
-23% -$487K 0.27% 121
2020
Q2
$2.14M Buy
+48,501
New +$2.05M 0.21% 144

Other funds holding XRAY

Dalton, Greiner, Hartman, Maher & Co's XRAY Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Dentsply Sirona (XRAY) in Q2 2021, closing a stake of 21,948 shares — an estimated $1.4M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in XRAY in Q2 2020 and held it in 4 quarters. The position peaked at $2.14M in Q2 2020. 574 funds tracked by Wall St. Rank hold XRAY as of Q2 2021.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Dentsply Sirona position as of Q2 2021 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 21,948 Dentsply Sirona shares in Q2 2021, an estimated $1.4M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Dentsply Sirona in Q2 2020 and held it in 4 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Dentsply Sirona position peaked at $2.14M in Q2 2020.
  • 574 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.